Results

Mitsubishi Tanabe Pharma Corporation

04/26/2019 | Press release | Distributed by Public on 04/25/2019 20:06

Mitsubishi Tanabe Pharma and Salix enter into a licensing agreement for MT-1303, a therapeutic agent for autoimmune diseases